LIVER INTERNATIONAL
Scope & Guideline
Connecting researchers and practitioners in the fight against liver disease.
Introduction
Aims and Scopes
- Metabolic Liver Disorders:
The journal consistently explores metabolic dysfunction-associated liver diseases (MAFLD) and its implications, emphasizing the relationship between metabolic syndrome, liver health, and overall patient outcomes. - Viral Hepatitis Research:
A significant portion of the publications focuses on hepatitis B and C, including new treatment strategies, epidemiology, and the challenges of achieving viral eradication and elimination. - Innovative Diagnostic Techniques:
Liver International highlights advancements in diagnostic methodologies, including non-invasive imaging and biomarkers, to assess liver disease progression and treatment efficacy. - Liver Cancer Studies:
Research on hepatocellular carcinoma (HCC) is a major focus, encompassing topics from early diagnosis and prognostic factors to treatment outcomes and novel therapeutic strategies. - Clinical Management and Guidelines:
The journal provides insights into clinical practices, treatment guidelines, and the integration of multidisciplinary approaches to improve liver disease management. - Socioeconomic and Public Health Impacts:
Articles often address the socioeconomic factors affecting liver disease prevalence and treatment access, highlighting disparities among different populations. - Drug-Induced Liver Injury:
The journal discusses the mechanisms and implications of drug-induced liver injury, providing insights into prevention, diagnosis, and management. - Emerging Therapies and Clinical Trials:
Research on new therapeutic agents and clinical trials is a recurring theme, focusing on innovative treatments for various liver diseases, including antiviral therapies and immunotherapies.
Trending and Emerging
- Metabolic Dysfunction and Liver Disease:
There is a significant increase in research focused on metabolic dysfunction-associated fatty liver disease (MAFLD) and its relationship with obesity, diabetes, and cardiovascular health. - Artificial Intelligence and Machine Learning Applications:
Emerging studies are increasingly applying AI and machine learning to predict liver disease outcomes, enhance diagnostic accuracy, and optimize treatment strategies. - Health Disparities and Social Determinants:
A growing body of work is examining the impact of socioeconomic factors on liver disease prevalence and treatment access, emphasizing the need for equitable healthcare solutions. - Long-term Outcomes Following Viral Hepatitis Treatment:
Increasing attention is being paid to the long-term outcomes of patients treated for chronic hepatitis B and C, including the risk of liver cancer and reinfection. - Integration of Gut Microbiome Research:
Research exploring the gut-liver axis and its implications for liver disease is on the rise, focusing on how gut health influences liver conditions. - Immunotherapy in Liver Cancer:
There is a notable trend toward investigating immunotherapeutic approaches for treating hepatocellular carcinoma, reflecting advancements in cancer treatment. - Non-invasive Monitoring Techniques:
The development and validation of non-invasive tools for assessing liver stiffness and fibrosis are gaining momentum, providing alternatives to traditional biopsy.
Declining or Waning
- Traditional Liver Biopsy Techniques:
There is a noticeable decline in studies focused on conventional liver biopsy techniques as non-invasive methods gain favor for diagnosing liver diseases. - Acute Liver Failure Studies:
Research specifically targeting acute liver failure has waned, possibly due to the increasing focus on chronic liver diseases and their long-term management. - Alcohol-Related Liver Disease Studies:
The frequency of publications solely addressing alcohol-related liver disease has decreased, which may reflect a broader shift toward understanding metabolic and multifactorial liver diseases. - Hepatitis E Research:
Interest in hepatitis E research appears to be declining, with fewer studies published in recent years as other liver diseases gain more attention.
Similar Journals
Hepatology Forum
Advancing liver health through innovative research.Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.
Annals of Hepatology
Advancing liver research, one article at a time.Annals of Hepatology is an esteemed open-access journal dedicated to the dynamic field of liver research and hepatology. Published by Elsevier España since 2002, this journal has established itself as a pivotal resource for researchers and clinicians alike, boasting a remarkable impact in the medical community with its 2023 rankings placing it in the Q2 quartile for Hepatology and Q1 quartile in Medicine (Miscellaneous). With an impressive Scopus rank of #20 out of 82 in the field of Hepatology and a notable 76th percentile standing, the journal is committed to disseminating high-quality, peer-reviewed articles that advance the understanding of liver diseases and their management. The editorial scope encompasses a broad range of topics, including liver pathology, therapeutic interventions, and public health implications related to hepatic disorders. Researchers, healthcare professionals, and students interested in the latest advancements in hepatology will find Annals of Hepatology an invaluable platform for sharing and accessing knowledge, with the convenience of open access enhancing global visibility and collaboration in this critical field of medicine.
Saudi Journal of Gastroenterology
Elevating standards in gastrointestinal research and practice.The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
Advancing the frontiers of digestive health.REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.
WORLD JOURNAL OF GASTROENTEROLOGY
Leading the way in gastrointestinal research excellence.WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.
JGH Open
Innovative Research, Accessible SolutionsJGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.
Egyptian Liver Journal
Empowering the hepatology community with vital knowledge.The Egyptian Liver Journal, ISSN 2090-6218, is a vital resource for the hepatology community, published by SPRINGEROPEN. Since its establishment in 2012, this journal has served as a platform for disseminating significant findings in liver research, with an emphasis on enhancing understanding and treatment of liver diseases. Recognized with a Q3 ranking in Hepatology for 2023, the Egyptian Liver Journal aims to bridge the gap between research and clinical practice through its commitment to open access, fostering a global exchange of knowledge without barriers since 2019. With a focus on innovative studies, reviews, and clinical guidelines, the journal appeals to a diverse audience of researchers, clinicians, and students dedicated to advancing liver health. Situated in the heart of the United States, this publication addresses the pressing issues within the field and encourages submissions that address the future of liver care and treatment.
DIGESTIVE AND LIVER DISEASE
Connecting professionals through groundbreaking studies.DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.
Liver Cancer
Advancing knowledge in liver cancer research.Liver Cancer is a premier, peer-reviewed journal dedicated to the comprehensive study and advancement of knowledge surrounding liver neoplasms. Published by KARGER and headquartered in Switzerland, this journal has been an open-access platform since 2012, providing researchers with invaluable insights into the rapidly evolving field of hepatology and oncology. With an impressive impact factor that places it in the Q1 category for both Hepatology and Oncology in 2023, Liver Cancer stands out as a high-impact conduit for groundbreaking research, ranking #19 out of 404 in Medicine _ Oncology and #6 out of 82 in Medicine _ Hepatology according to Scopus. Researchers, practitioners, and students are encouraged to engage with the journal's content, which encompasses clinical studies, basic research, and reviews that contribute significantly to understanding liver cancer dynamics, diagnosis, and treatment strategies. This journal not only facilitates the dissemination of knowledge but also fosters collaboration in a well-established and impactful global scientific community.
JHEP Reports
Empowering global health through accessible scholarship.JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.